Analyst Ratings For Canopy Growth Corp (NYSE:CGC)
Today, Jefferies Financial Group initiated coverage on Canopy Growth Corp (NYSE:CGC) with a Hold.
There are 4 Hold Ratings, 4 Buy Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.
The current consensus rating on Canopy Growth Corp (NYSE:CGC) is Buy with a consensus target price of $55.7567 per share, a potential 25.18% upside.
Some recent analyst ratings include
- 2/25/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Hold rating
- 2/21/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Neutral ➝ Neutral rating and $46.27 price target
- 2/19/2019-Canopy Growth Corp (NYSE:CGC) gets downgraded to Hold by GMP Securities
- 1/18/2019-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Sector Outperform ➝ Outperform rating
- 10/17/2018-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Hold rating and $61.00 price target
- 9/25/2018-Canopy Growth Corp (NYSE:CGC) has coverage initiated with a Buy ➝ Buy rating
About Canopy Growth Corp (NYSE:CGC)
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Recent Trading Activity for Canopy Growth Corp (NYSE:CGC)
Shares of Canopy Growth Corp closed the previous trading session at 44,54 −0,50 1,11 % with 44.02 shares trading hands.
